Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
In Vivo (Athens, Greece)|June 30, 2026
Increasing Ablation Area Using the Arfa Ablation System: An Experimental Study in the Bovine LiverToru Ishikawa, Hiroshi Hirosawa, Yuzo Tanabe, et al.
Translational Gastroenterology and Hepatology|May 8, 2024
Serum zinc concentration as a potential predictor of presarcopenia in patients with chronic liver disease: a preliminary studyMitsuyuki Suzuki, Toru Ishikawa, Kazuki Ohashi, et al.
Journal of Clinical Medicine|April 30, 2021
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver DiseaseKazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Journal of Clinical Medicine Research|October 23, 2019
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver DiseaseKazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Experimental and Therapeutic Medicine|September 25, 2020
Effect of levocarnitine administration in patients with chronic liver diseaseKazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Journal of Hepatocellular Carcinoma|June 28, 2023
Comparison of Ablation Volume Between Emprint<sup>®</sup> and Mimapro<sup>®</sup> Systems for Hepatocellular Carcinoma -A Preliminary StudyToru Ishikawa, Iori Hasegawa, Hiroshi Hirosawa, et al.
Clinical and Experimental Hepatology|April 28, 2025
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinomaToru Ishikawa, Hiroshi Hirosawa, Tsubasa Honmou, et al.
In Vivo (Athens, Greece)|April 27, 2023
<i>Ex Vivo</i> Experimental Study of the Ablation Area of Bovine Liver Using STARmed Radiofrequency AblationToru Ishikawa, Iori Hasegawa, Hiroshi Hirosawa, et al.
In Vivo (Athens, Greece)|March 7, 2023
An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular CarcinomaToru Ishikawa, Iori Hasegawa, Hiroshi Hirosawa, et al.
Experimental and Therapeutic Medicine|February 6, 2018
Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patientsKazuki Ohashi, Toru Ishikawa, Mitsuyuki Suzuki, et al.
Pageof 2